Australia markets closed

Genovate Biotechnology Co., Ltd. (4130.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
24.40+0.05 (+0.21%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 2.66B
Enterprise value 2.15B
Trailing P/E 81.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.97
Price/book (mrq)1.79
Enterprise value/revenue 4.02
Enterprise value/EBITDA 29.21

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-17.88%
S&P500 52-week change 325.22%
52-week high 331.60
52-week low 323.60
50-day moving average 324.25
200-day moving average 325.74

Share statistics

Avg vol (3-month) 3182.03k
Avg vol (10-day) 3169k
Shares outstanding 5109.38M
Implied shares outstanding 6110.5M
Float 879.66M
% held by insiders 13.69%
% held by institutions 127.23%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.18
Forward annual dividend yield 40.72%
Trailing annual dividend rate 30.15
Trailing annual dividend yield 30.62%
5-year average dividend yield 41.29
Payout ratio 458.33%
Dividend date 3N/A
Ex-dividend date 406 July 2023
Last split factor 21020:1000
Last split date 310 Sept 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.14%
Operating margin (ttm)13.69%

Management effectiveness

Return on assets (ttm)1.22%
Return on equity (ttm)2.20%

Income statement

Revenue (ttm)536.3M
Revenue per share (ttm)4.90
Quarterly revenue growth (yoy)5.90%
Gross profit (ttm)N/A
EBITDA 65.65M
Net income avi to common (ttm)32.92M
Diluted EPS (ttm)0.30
Quarterly earnings growth (yoy)27.40%

Balance sheet

Total cash (mrq)508.82M
Total cash per share (mrq)4.65
Total debt (mrq)324k
Total debt/equity (mrq)0.02%
Current ratio (mrq)5.86
Book value per share (mrq)13.63

Cash flow statement

Operating cash flow (ttm)52.12M
Levered free cash flow (ttm)6.29M